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Strobilanthes crispus leaves extracts (SCE) induced lipolysis and increased 
leptin level in diet-induced obese rats fed high-fat diet
Abstract
The aim of the present study was to assess the anti-obesity and lipolysis effects of Strobilanthes 
crispus leaves extract (SCE) in diet-induced obese (DIO) rats by administering 1% (w/w) of 
SCE in drinking water. Methods: Normal Sprague-Dawley rats were induced obese using a 
high-fat (HF) diet formulation for 14 weeks. DIO rats were subsequently treated with 1% (w/w) 
SCE while the HF diet was switched to normal rat chow diet. Food intake, water intake and 
bodyweight were measured weekly. Other parameters e.g. blood lipid profile were determined 
in normal and DIO rats before and after treatment with SCE. Histopathological changes in the 
liver were also observed after treatment. Results: Prior to treatment, DIO rats have significantly 
higher (p <0.05) bodyweight, adipose tissue and liver weight, plasma leptin levels, lower 
adipose tissue lipolysis rate and severe fatty livers and the trend continues in non-treated DIO 
rats served as Control group. DIO rats treated with SCE significantly (p <0.05) reduced their 
bodyweight gain, have lower adipose tissue and liver weight, lower leptin level and increased 
lipolysis rate although no significant effect was found in total bodyweights of treated group. 
Lower glucose level and improved state of fatty liver was also noted in SCE treated group.  The 
observed anti-obesity effects are most likely the due to lipolysis. Conclusion: SCE may, at least 
in part, be attributed to the anti-obesity effects found on treated DIO rats. 
Introduction
Obesity prevalence is increasing worldwide at 
an alarming rate in both developed and developing 
countries. Obesity has reached epidemic proportions 
globally, and all this evidence suggests that the 
situation is likely to get worse. Obesity is now 
epidemic in developed nations including Australia, 
New Zealand and Singapore and is rapidly becoming 
so in many developing populations, particularly 
Pacific Islanders and certain Asian nations (WHO, 
1998). Obesity involves complex aetiological 
links between the genetic, metabolic and neural 
frameworks on one hand and behavior, food habits, 
physical activity and socio-cultural factors on the 
other (Nammi et al., 2004). 
In the past a variety of drugs that influence appetite, 
energy expenditure, or both were used; however, all 
have been found to cause serious side effects and are 
considered inappropriate for the pharmacological 
treatment of obesity (Acheson and Tappy, 2004). 
For example, Rimonabant, a selective blocker of 
the cannabinoid receptor CB1 is associated with 
psychiatric problems (mainly depression and anxiety) 
and the marketing authorization of the relevant drug 
was suspended by the European Medicines Agency 
(EMA) in 2008. Sibutramine, a centrally acting agent 
that inhibits serotonin and norepinephrine reuptake; 
marketing authorization of the relevant drugs was 
suspended by EMA in 2010 due to association with 
increases in heart rate and blood pressure. Finally, 
orlistat, a triacylglycerol lipase inhibitor that works in 
the intestinal lumen to reduce dietary fat absorption 
produces gastrointestinal side effects (as abdominal 
pain, fecal urgency etc) in 15–30% of the patients 
under treatment (Fragkiadakis et al, 2010).
Research studies are being carried out to detect 
and confirm the action of drugs and natural products 
that yield better and long-lasting results in terms of 
weight reduction (Gurib-Fakim, 2006). Plants or 
medicinal herbs can contribute to prevent or treat 
obesity through many factors including inhibition of 
lipases, increased thermogenesis, increased satiety 
and reduced stress. Some medicinal plant preparations 
can be usefully associated to diet therapy (Gurib-
Fakim, 2006). 
The biochemical properties of S. crispus show 
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native to countries from Madagascar to Indonesia, 
and commonly known as daun picah beling in 
Indonesia (Sunarto, 1977). This bush-like plant can 
be found on riverbank or abandoned field while 
some Javanese use this plant as fence. Previous 
research has found the plant to have antidiabetic, 
diuretic, antilytic, and laxative effects (Perry and 
Metzger, 1980). One study found that the main active 
compounds of S. crispus are phenolic acids (Sergent 
et al., 2012). Phenolic compounds have now been 
shown to have the capacity of preventing obesity 
(Maznah et al., 2000). The plant also has many 
cystoloths of calcium carbonate and an infusion is 
mildly alkaline (Perry and Metzger, 1980). High 
levels of total ash (21.6%) in the dried plant leaves 
were the result of high content of minerals such as 
potassium (10,900 mg/100 g sample), followed by 
calcium (5,185 mg/100 g sample) (Zemel, 2002). 
It has been proposed that dietary calcium regulates 
energy metabolism and lipolysis (Xue et al., 2001) 
by modulating intracellular phosphodiesterase and 
fatty acid synthase activities (Lissner et al., 1987).
However, until now, no study has been done to 
investigate the potential of S. crispus leaves in the 
treatment of obesity. The local consumption of S. 
crispus as tea and claims that it can control body 
weight combined with its biochemical properties 
and in vivo effects has sparked the initiation of the 
investigation on health-promoting potentials of S. 
crispus as an anti-obesity agent. Thus, we evaluated 
the anti-obesity effect of 1% (w/w) S. crispus leaves 




 54 male adult male Sprague-Dawley rats aged 
3 months weighing 350-450 g were purchased 
from Perniagaan Usaha Cahaya (Malaysia). These 
animals were of the same age and delivered from the 
supplier in the same batch. Upon received, rats were 
acclimatized for 7 days by giving ad libitum normal 
rat chow and water in the animal house. During all 
experiments, rats were housed in a temperature-
controlled room (22±2oC) with a 12-hour light/
dark cycle. Protocols for animal experiments were 
approved by the Animal Care and Use Committee 
(ACUC) of Faculty of Medicine and Health Sciences, 
Universiti Putra Malaysia.
Diet composition
The ingredients of normal rat chow pellets 
obtained from Miba Mansura (Malaysia) were: palm 
kernel meal (26%), soybean oil (4%), cornstarch 
(46%), mineral mixture (3.5%), vitamins mixture 
(1%), L-cystine (0.18%), choline bitartrate (0.25%). 
The diet was formulated from the AIN-93M diet 
for maintenance of rodents when casein is used as 
the protein source (18) and modified. HF diet was 
prepared from a mixture of 50% normal rat chow 
pellet (Miba Mansura Trading, Malaysia), 20% of 
full-cream milk powder (Nespray brand from Nestlé), 
6% sugar and 24% of corn oil (Mazola brand). The 
diet contained 40.5% carbohydrate, 16.1% protein, 
31.1% fat, 2.5% fiber and 5.1% ash. Proximate 
composition was expressed as % weight of diet and 
was calculated by the researchers.
Preparation of Strobilanthes crispus extract (SCE)
Strobilanthes crispus ZII 109 (L.) Bremek (family 
Acanthaceae) leaves were taken from Botanical 
Garden of Faculty of Medicine and Health Sciences, 
Universiti Putra Malaysia. The collected leaves were 
cleaned with tap water and immediately dried on 
an air oven (Memmert, Schwabach, Germany) at 
40°C overnight. Dried leaves were grinded to fine 
powder using an electric blender (Philips, Malaysia). 
Powdered leaves were sealed in plastic bags and kept 
at 4˚C before use. To obtain crude extract, powdered 
leaves were soaked and stirred continuously with 
chloroform-methanol (5:3) for 12 hours. Crude 
extract within solvents was poured onto a round 
flask before being connected to a rotary evaporater 
(Rotavapor® R-210/R-215, Büchi, Switzerland) to 
remove the solvents. Solvent-free crude extracts 
were stored at -20°C before further use.
Induction of obesity
High-Fat Diet (HFD) treatment was started 
at Week 1 after rats were randomly divided into 
two groups: Normal diet group (n=12) and HFD 
group (n=42). Food and water for both groups were 
given ad libitum. At Week 14, the body weight and 
body weight gain of both groups were statistically 
analyzed. Rats from HFD group were considered as 
diet-induced obese (DIO) if their bodyweight is 30% 
more than Normal diet group. Six rats from Normal 
diet group and 6 DIO rats were sacrificed to obtain 
the Baseline data. 
Experimental design
Six rats from Normal diet group and 12 DIO rats 
from the previous experiment were used. Rats were 
assigned to 3 groups of: a) Negative control, normal 
rats (n=6), b) Positive control, DIO rats (n=6) and 
c) Treatment group, DIO rat treated with SCE (n=6). 
However, towards the end of the experiment, positive 
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control group only consisted of 5 rats as 1 had died 
because of mishandling. All groups were given 
normal rat chow.  Negative control and Positive 
control group were given tap water while Treatment 
group were given SCE in drinking water. At Week 
28, rats were sacrificed to obtain the Final data. 
Food intake, body and organ weight
The amount of food taken by rats in each cage 
and their individual bodyweight were recorded 
once a week using an electrical balance (AND, HR-
200, Singapore). Adipose tissue was dissected from 
adipose depots consisted of the left and right inguinal, 
retroperitoneal adipose depots, and mesenteric 
adipose depot. Liver, left and right kidneys, heart and 
pancreas were also dissected. All of these organs and 
tissues were weighed.
Biochemical parameters
Blood withdrawn from the cardiac puncture of 
each rat were collected into separate EDTA tubes. 
Blood glucose level were determined using a glucose 
monitoring system (True Track Smart System Meter®) 
purchased from Home Diagnostics Inc., USA. The 
remaining tubes were centrifuged at 3000 RPM, 4°C 
for 15 minutes to obtain the plasma. To obtain the total 
cholesterol, triglycerides, HDL and LDL levels, 50 µl 
of plasma was analyzed using an automated clinical 
chemistry analyzer (Hitachi 902, Roche Diagnostics). 
Leptin level was analyzed using a Rat Leptin Assay 
Kit (L) (IBL Co. Ltd., Japan - Code No. 27295) 
purchased from All Eights Sdn. Bhd. (Malaysia). The 
IBL’s Rat Leptin Enzyme Immunoassay Kit (L) is 
a complete kit for the quantitative determination of 
Rat Leptin in serum, EDTA-plasma and supernatant 
of cell culture media. Plasma glycerol level was 
analyzed using a Glycerol Colorimetric kit purchased 
from Randox Laboratories (Malaysia). 
Liver histology analysis
Livers were cut on the same lobe for each sample 
to obtain a small sample and fixed in 10% formalin 
for further use. Prior to staining, liver tissues were 
dehydrated in a tissue processor machine (Leica 
TP1020, Germany) and blocked using paraffin wax. 
Blocks were kept at 0ºC for 3 hours, before tissues 
were trimmed at 4µm per layer using a microtome 
(Letiz Wetzlar 1512, Germany) to 4 μm and pasted on 
slides and dried on a hot plate at 50-55ºC for 30 min 
and then kept at 37ºC. Routine Mayer’s Haematoxylin 
and Eosin (H & E) staining method was used. After 
perfectly dried from xylene (Ajax Chemicals, Auburn, 
Australia), the slides were mounted with cover slips 
and a drop of DPX mountant for microscopy. The 
slides were then dried at room temperature for two 
days and tested under a light microscope (Olympus 
CK2, Japan).
Statistical analysis
Data was analyzed using SPSS window program 
version 22.0. Comparison for each of the clinical 
variables was done using Independent T-test for 
comparisons of 2 groups and 1-way ANOVA for 
comparisons using more than 2 groups. Significant 
interactions were analyzed with Tukey post-hoc test 
and Tukey corrected p-values <0.05 were considered 
significant.
Results and Discussion
High-fat diet induced obesity in rats
 During induction of obesity, although the amount 
of food intake in rats fed high-fat diet is similar to the 
rats fed normal rat chow diet, their caloric intake was 
significantly different (p <0.05). Mean energy intake 
per day per rat during the whole 14 weeks of diet 
treatment differed significantly (p <0.05) between the 
Normal group and HF diet group indicating that HFD 
group did not decrease their food intake despite the 
high calories provided by the diet given. The higher 
energy intake per day in HFD group also resulted in 
higher bodyweights. At Week 14, 18 rats in the HFD 
group became obese (O) with significantly (p <0.05) 
higher mean weight gain than Normal rats. Feed 
efficiency was increased in the HFD group although 
not significant (Table 1).
High-fat diets often promote greater caloric 
intake and/or weight gain than lower fat diets, as 
revealed by multiple research paradigms including 
epidemiological studies, experimental manipulation 
of dietary fat content in human subjects, and animal 
models of diet-induced overeating (Warwick and 
Schiffman, 1992; Warwick and McGuire, 2000). 
The same case applied to this experiment. It was 
found that HF group consumed almost double the 
energy consumed by the Normal group. This result 
is not in line with the traditional belief that fat is the 
macronutrient with the strongest satiety property. 
Presumably, foods with high satiation or satiety value 
should aid in controlling energy intake, whereas items 
with low values should provide a weaker barrier 
to consumption. However, more recent literature 
provides compelling evidence that fat is actually the 
least satiating of the macronutrients (Blundell and 
Mac Diarmid, 1997; Tso and Liu, 2004).
Normal diet group during induction of obesity 
consumed normal rat chow, where significantly less 
bodyweight gain was found compared to HFD group 
1118  Zawawi et al./IFRJ 23(3): 1115-1122
which consumed high-fat diet (Table 1). Consumption 
of a diet high in fat is often associated with greater 
caloric intake and weight gain than occurs on a low 
fat diet. This has been revealed in epidemiological 
studies, via experimental manipulation of dietary 
fat content using human subjects, and in animal 
models of dietary-induced overeating (Warwick 
and Schiffman,1992; Warwick and McGuire, 2000). 
Higher feed efficiency was also found in HFD group 
compared to Normal Diet Groups. Obese rats utilized 
the most of its energy intake to increase weight gain 
as been found by other similar studies (Levin et al, 
1997; Yang et al, 2001; Dourmashkin et al, 2006; Lee 
et al, 2006). 
Except for the low HDL level, Obese rats did 
not show the attributes usually found in rats given 
high-energy diet such as higher cholesterol, LDL and 
cholesterol level compared to Normal rats (Moreno 
et al, 2006; Ono et al, 2006). Two earlier studies 
(Gao et al, 2002; Kusunoki et al, 2005) have shown 
that the level of triglycerides in rats given HF diet 
was far greater than the level of triglycerides found 
in this experiment. The high-fat diet given to HFD 
group did not induce high level of triglycerides in the 
blood. Plasma HDL level in found in this experiment 
is similar to a study done by Kusunoki and colleagues 
(2005) which is 1.31 mmol/l in rats fed normal rat 
chow diet and 1.33 mmol/l in rats fed high-fat diet. 
 Among all the organs weights measured, the only 
significant differences (p <0.05) found between the 
two groups were of adipose tissue and liver weight. 
Adipose tissue weight of HFD group was found to be 
114% higher while liver weight was 16% higher than 
Normal group (Table 1). Moreover, from observation, 
liver of HFD group was seen to be milky in color 
compared to the dark red colour of Normal diet group. 
Further histology analysis confirmed high amount of 
fat had accumulated in the liver of HFD group based 
on the amount of white circles (lipid droplets) in the 
liver cells (Figure 1). Animal studies done by many 
others also confirmed that diet-induced obese rats 
given high-energy diet developed fatty liver based 
on the milky color of the liver, by its’ higher weight 
and by H&E staining method compared to Normal 
rats given normal rat chow diet (Takeda et al, 2001; 
Morimoto et al, 2005; Moreno et al, 2006). 
Effect of SCE on food intake, feed efficiency, body 
weight of rats
 During treatment with SCE, the diet of high-
fat diet induced obese rats was switched to normal 
rat chow. Despite the changes in diet, food intake 
remained constant in all groups. Other studies have 
shown that over the course of a few days, the weight 
of the food consumed was more constant than the 
calories eaten (Poppitt and Prentice, 1996; Rolls and 
Bell, 2000; Yao and Roberts, 2001; Kral and Rolls, 
2004).
Mean food intake per day in all 14 weeks of 
treatment was found to be not significant between 
the groups. As all of the rats consumed the same 
diet, this means that the energy intake between the 
groups were also similar. However, bodyweight 
gain per week of Treatment Group was found to be 
significantly lower than both Negative and Positive 
Control Groups (Table 1). This leads to significantly 
lower feed efficiency in the Treatment Group. 
Although lower feed efficiency in Treatment  Group 
should lead to bodyweight reduction, no statistically 
Table 1. Bodyweight, food intake, organ weights and lipolysis rate
NT - Data were not taken
All data are means ±SD. Significant differences in Diet Effects Data were statistically analyzed using t-test. Significance 
were valued at p<0.05 and marked with *. Significant differences in Treatment Effects Data were statistically analyzed 
using one-way ANOVA. Significance were valued at p<0.05 and marked with different alphabet.
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significant difference in the bodyweight of all groups. 
Even though there was no significant difference (p 
>0.05) between the total body weight gain in all of the 
groups, the value at Week 28 increased in the order of 
Negative Control Group<Treatment Group<Positive 
Control Group (Table 1). 
Effect of SCE on leptin level, lipid and glucose profile
Treatment with SCE had significantly (p<0.05) 
lowered the plasma leptin level. No significant (p 
>0.05) differences was found in the plasma glucose 
and lipid level of rats in all groups (Table 2). 
However, it is worthy of note that the mean plasma 
TG, cholesterol and blood glucose level in Positive 
Control group was found to be the highest of all 
groups.
Results from the treatment shown that SCE had no 
significant effect on plasma lipid profile even though 
some mild effect on TG and cholesterol lowering 
were noted (Table 2). The TG level found in this 
experiment is similar to studies done by Kwon with 
colleagues (2003) and Nakayama with colleagues 
(2007). Nakayama (2007) found that control rats 
given high-fat diet had a TG level of 0.56mmol/l 
while rats given high-fat diet with Chinese herbal 
medicines had TG level of 0.34mmol/l. In another 
study, Kwon (2003) found that control rats given high-
fat diet had a TG level of 0.66mmol/l compared to 
rats given high-fat diet with 5% Dioscorea nipponica 
methanol extract had a TG level of 0.46mmol/l. Thus 
SCE had better effect on TG lowering than Dioscorea 
nipponica methanol extract. We can also conclude 
that normal rat chow had did not change the lipid 
profile of Positive Control group even though their 
diet was switched.
The effect of SCE on plasma glucose level, 
Table 2. Plasma glucose, leptin and lipid profile
NT - Data were not taken
All data are means ±SD. Significant differences in Diet Effects Data were statistically analyzed using t-test. Significance 
were valued at p<0.05 and marked with *. Significant differences in Treatment Effects Data were statistically analyzed 
using one-way ANOVA. Significance were valued at p<0.05 and marked with different alphabet.
Figure 1. Histology analysis of liver after induction of obesity
The liver of rats fed the standard rat chow diet is normal and shows very mild occurrence hepatic 
steosis (1A, 1B, 1C). The livers of the Obese rats fed HF diet showed pronounced hepatic steosis 
(2A, 2B, 2C). Note: Pictures 1A and 2A - magnified 40X, 1B and 2B - magnified 20X, 1C and 2C 
–magnified 10X.
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although not significant, it was definitely lower than 
Positive Control Group. Similar results was found by 
Gao and colleagues (2002), where diet-induced obese 
Sprague-Dawley rats were maintained on a high-fat 
diet for 6 months followed by a low-fat diet for 1 
month. They found that even though high-fat diet 
was switched to low-fat diet, rats failed to lower their 
glucose level. In this experiment, glucose level in 
Treatment group was decreased by 32.8% compared 
to Positive Control group which may suggest that 
SCE may also have anti-diabetes properties.
Effect of SCE on lipolysis, organ weights and liver 
morphology
Treatment with SCE has also lowered (p<0.05) 
adipose tissue and liver weights of Treatment Group. 
When calculated, the significantly lower adipose 
tissue weight is an indicator of significantly (p<0.05) 
higher lipolysis rate in Treatment Group (Table 1). 
The lipolysis rate increased in the order of Positive 
Control Group<Negative Control Group<Treatment 
group (Table 1). No significant differences (p >0.05) 
were found in the kidney, heart and pancreas weight 
of all groups (Table 1). Adipose tissue weight was 
highest in Positive Control group, followed by 
Negative Control and Treatment group. Liver weight 
also followed the same pattern (Table 1).
Occurrence of hepatic steatosis had decreased 
(Figure 2) in Treatment group compared to Positive 
Control Group. Livers of Treatment group show 
similar degree of mild hepatic steatosis as Negative 
Control group. At Week 28, Positive Control group, 
however, had developed a severe case of hepatic 
steatosis (Figure 2), more severe than HFD group 
at Week 14 (Figure 1). Histology analysis on the 
liver had support the suggestion derived from 
adipose tissue and liver weights data. The livers of 
Treatment group had been found to improve their 
color appearances and have a lower degree of hepatic 
steatosis compared to Positive group (Figure 3.0). 
Weight loss of adipose tissue and liver after/
during treatment with suspected anti-obese plants 
or herbs or compounds had been associated with 
body weight loss and an improved state of obesity. 
Raspberry ketone, a major aromatic compound of 
red raspberry (Marimoto et al., 2005), Diocorea 
nipponica methanol extract (Kwon et al., 2003), 
Arachis hypogaea nutshell extract (Moreno et al, 
Figure 2. Histology analysis of liver after treatment with SCE
Note: The liver of Obese group showed pronounced hepatic steatosis (2A, 2B, 2C). 
Normal (1A, 1B, 1C) and OT (3A, 3B, 3C) groups showed mild occurrence of hepatic 
steatosis. Pictures were magnified (A - 10X, B – 20X, C – 40X).
Figure 3. Bodyweight changes before and after treatment 
with SCE
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2006), Chinese herbal medicines: Inchinko-to, Bofu-
tsusho-san and dai-saiko-to (Nakayama et al., 2007) 
and Nelumbo nucifera leaves extract (Ono et al, 
2006) were also found to lower adipose tissue and/or 
liver weights after/when given HF diet. 
Conclusions
In summary, the formulation that we had 
developed had successfully induced obesity in 
Sprague-Dawley rats. The diet-induced obese rats 
had all the physical and biochemical attributes of 
obesity that is similar to the human obesity. The state 
of obesity in HFD group remained persistent even 
though diet was switched to normal rat chow diet 
in the Positive Control group. Treatment with SCE 
had improved their state of obesity with significantly 
lower bodyweight gain, leptin level, adipose tissue 
and liver weight, higher lipolysis rate, better liver 
color and improved state of hepatic steatosis even 
though there was no significant effect on bodyweight 
loss. Profoundly, the positive effect of S. crispus in 
assisting adipose tissue weight loss can be due to the 
enhanced rate of adipose tissue lipolysis. Thus, we 
can conclude that 1% (w/w) S. crispus extract may, in 
part, play a role in adipose tissue weight loss of DIO 
rats but more studies needs to be done in determining 
the dose response effects of SCE to verify the best 
dose. It is also necessary to investigate the effect of 
SCE on obesity related gene expression to determine 
the specific mechanisms involved in the lipolysis 
effect of SCE.
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